Search

Search Constraints

You searched for: Author/Creator Ledermann, Jonathan

Search Results

1. 2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer: Report From the Fourth Ovarian Cancer Consensus Conference. Issue 4 (1st April 2011)

2. 596 A randomised phase II study of nintedanib (BIBF1120) compared to chemotherapy in patients with recurrent clear cell carcinoma of the ovary or endometrium. (NICCC/ENGOT-OV36). (14th December 2020)

4. Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer – a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34). Issue 12 (30th June 2020)

5. Best original research presented at the 23rd European Congress on Gynaecological Oncology—Best of ESGO 2022. Issue 2 (15th December 2022)

6. British Gynaecological Cancer Society (BGCS) epithelial ovarian/fallopian tube/primary peritoneal cancer guidelines: recommendations for practice. (June 2017)

7. British Gynaecological Cancer Society recommendations and guidance on patient-initiated follow-up (PIFU). Issue 5 (19th April 2020)

8. British Gynaecological Cancer Society recommendations for women with gynecological cancer who received non-standard care during the COVID-19 pandemic. Issue 1 (18th November 2021)

9. British Gynaecological Cancer Society Recommendations for Women With Gynecological Cancer Who Received Non-standard Care During the COVID-19 Pandemic. Issue 3 (March 2022)

10. British Gynaecological Cancer Society Recommendations for Women With Gynecological Cancer Who Received Non-standard Care During the COVID-19 Pandemic. Issue 3 (March 2022)